EP2999711
Fjölmýxínafleiður og notkun þeirra í samsetta meðferð ásamt mismunandi sýklalyfjum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
21.5.2014EP published:
29.6.2022EP application number:
14726731.4
EP translation filed:
8.8.2022Grant published:
15.9.2022EPO information:
European Patent Register
Max expiry date:
20.5.2034Expiry date:
20.5.2026Next due date:
31.5.2026
Title in English:
POLYMYXIN DERIVATIVES AND THEIR USE IN COMBINATION THERAPY TOGETHER WITH DIFFERENT ANTIBIOTICSLanguage of the patent:
English
Timeline
Today
21.5.2014EP application
29.6.2022EP Publication
8.8.2022Translation submitted
15.9.2022Registration published
20.5.2026Expires
Owner
Name:
Spero Therapeutics, Inc.Address:
675 Massachusetts Avenue, 14th Floor, Cambridge, MA 02139, US
Inventor
Name:
BROWN, PamelaAddress:
Reading Berkshire RG1 8LS, GB
Name:
DAWSON, MichaelAddress:
Reading Berkshire RG1 8LS, GB
Name:
SIMONOVIC, MonaAddress:
Reading Berkshire RG1 8LS, GB
Name:
BOAKES, StevenAddress:
Reading Berkshire RG1 8LS, GB
Name:
DUPERCHY, EstherAddress:
Reading Berkshire RG1 8LS, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201309248Date:
22.5.2013Country:
GB
Number:
201404301Date:
11.3.2014Country:
GB
Classification
Categories:
C07K 7/62, A61K 38/12
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 2.3.2023
Expires: 20.5.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 12.4.2024
Expires: 20.5.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 5.5.2025
Expires: 20.5.2026
Payer: Árnason Faktor ehf.